Skip to main content
Top
Published in: Child's Nervous System 11/2017

01-11-2017 | Original Paper

LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT)

Authors: Shilpa Rao, R. T. Rajeswarie, T. Chickabasaviah Yasha, Bevinahalli N. Nandeesh, Arimappamagan Arivazhagan, Vani Santosh

Published in: Child's Nervous System | Issue 11/2017

Login to get access

Abstract

Introduction

CNS embryonal tumors comprise a group of highly malignant neoplasms with a wide spectrum of histomorphological entities that includes Medulloblastoma (MB), Atypical Teratoid/Rhabdoid Tumor (AT/RT), Neuroblastoma (NB), Ganglioneuroblastoma (GNB), Embryonal Tumor with Multilayered Rosettes (ETMR), and the embryonal tumor—Not Otherwise Specified (NOS). The entity ETMR includes previously described histopathologic patterns—Embryonal Tumor with Abundant Neuropil and True Rosettes (ETANTR), Ependymoblastoma (EBL), and Medulloepithelioma (MEPL). Based on the histopathological similarities (multilayered rosettes) among ETANTR, EBL, and MEPL, as well as uniform clinical behavior and common molecular genetic characteristics, the WHO revision has created a new entity, “ETMR.” Immunoreactivity of LIN28A has been identified as a sensitive tool for the diagnosis of this entity. Since there is a paucity of literature regarding immunoreactivity of LIN28A across all embryonal CNS tumors, the present study was undertaken.

Materials and methods

During the 5-year study period (2012 to 2016), all the embryonal tumors (MB, AT/RT, other embryonal tumors—ETANTR, MEPL, PNET) that had been earlier diagnosed in the department of neuropathology (cases operated in our institute as well as received as referral) were reviewed. The archived Hematoxylin and Eosin (H&E) and the available immunohistochemistry (IHC) sections were studied. Further, for the other embryonal tumors where the paraffin blocks were available, an extended panel of IHC was performed for confirming the diagnosis of embryonal tumor and only confirmed cases were included in the study. The demographic details of the study cohort were noted. IHC for LIN28A was performed on conventional sections.

Results

A total of 396 cases of embryonal tumors including 302 MB, 72 AT/RT, and 22 other embryonal tumors were diagnosed during the study period. Among these, 80 MB, 35 AT/RT, 4 ETANTR, 1 MEPL, 4 NB, 2 GNB, and 1 CNS embryonal tumor-NOS (total—127) were included for the study. LIN28A immunoreactivity was absent in all MB, GNB, NB, and CNS embryonal tumors-NOS whereas all cases of ETMR (4 ETANTR, 1 MEPL) and 8/35 (23%) of AT/RT showed immunopositivity for LIN28A, which was patchy and distinct in most of the cases of ETMR.

Conclusion

Our study reiterates that LIN28A is a sensitive IHC marker for the diagnosis of ETMR. We also show that among CNS embryonal tumors, LIN28A is not specific to ETMRs and such immunoreactivity can also be seen in a proportion of AT/RTs.
Literature
1.
go back to reference In: Louis DN, Ohgaki H, Weistler OD, Cavenee WK, eds. WHO classification of tumors of central nervous system. 4th ed. Lyon, France: IACR Press; 2016 In: Louis DN, Ohgaki H, Weistler OD, Cavenee WK, eds. WHO classification of tumors of central nervous system. 4th ed. Lyon, France: IACR Press; 2016
3.
go back to reference Gupta T, Shirsa N, Jalali R (2015) Molecular subgrouping of medulloblastoma: impact upon research and clinical practice. Curr Pediatr Rev 11:106–119CrossRefPubMed Gupta T, Shirsa N, Jalali R (2015) Molecular subgrouping of medulloblastoma: impact upon research and clinical practice. Curr Pediatr Rev 11:106–119CrossRefPubMed
4.
go back to reference Gilbertson R (2002) Paediatric embryonic brain tumours. Biological and clinical relevance of molecular genetic abnormalities. Eur J Cancer 38:675–685CrossRefPubMed Gilbertson R (2002) Paediatric embryonic brain tumours. Biological and clinical relevance of molecular genetic abnormalities. Eur J Cancer 38:675–685CrossRefPubMed
5.
go back to reference Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME et al (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436–442CrossRefPubMed Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME et al (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436–442CrossRefPubMed
6.
go back to reference Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060–1072CrossRefPubMedPubMedCentral Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060–1072CrossRefPubMedPubMedCentral
7.
go back to reference Embryonal tumors. In: Louis DN, Ohgaki H, Weistler OD, Cavenee WK, eds. WHO classification of tumors of central nervous system. Revised 4th ed. Lyon, France: IACR Press; 2016 Embryonal tumors. In: Louis DN, Ohgaki H, Weistler OD, Cavenee WK, eds. WHO classification of tumors of central nervous system. Revised 4th ed. Lyon, France: IACR Press; 2016
8.
go back to reference Judkins AR, Ellison DW (2010) Ependymoblastoma: dear, damned, distracting diagnosis, farewell! Brain Pathol 20:133–139CrossRefPubMed Judkins AR, Ellison DW (2010) Ependymoblastoma: dear, damned, distracting diagnosis, farewell! Brain Pathol 20:133–139CrossRefPubMed
9.
go back to reference Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C et al (2009) Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell 16:533–546CrossRefPubMedPubMedCentral Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C et al (2009) Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell 16:533–546CrossRefPubMedPubMedCentral
10.
go back to reference Korshunov A, Remke M, Gessi M, Ryzhova M, Hielscher T, Witt H et al (2010) Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes. Acta Neuropathol (Berl) 120:253–260CrossRef Korshunov A, Remke M, Gessi M, Ryzhova M, Hielscher T, Witt H et al (2010) Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes. Acta Neuropathol (Berl) 120:253–260CrossRef
11.
go back to reference Paulus W, Kleihues P (2010) Genetic profiling of CNS tumors extends histological classification. Acta Neuropathol (Berl) 120:269–270CrossRef Paulus W, Kleihues P (2010) Genetic profiling of CNS tumors extends histological classification. Acta Neuropathol (Berl) 120:269–270CrossRef
12.
go back to reference Korshunov A, Ryzhova M, Jones DTW, Northcott PA, van Sluis P, Volckmann R et al (2012) LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathol (Berl) 124:875–881CrossRef Korshunov A, Ryzhova M, Jones DTW, Northcott PA, van Sluis P, Volckmann R et al (2012) LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathol (Berl) 124:875–881CrossRef
13.
go back to reference Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y et al (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 15:1–56CrossRef Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y et al (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 15:1–56CrossRef
14.
go back to reference Gessi M, Giangaspero F, Lauriola L, Gardiman M, Scheithauer BW, Halliday W et al (2009) Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor. Am J Surg Pathol 33:211–217CrossRefPubMedPubMedCentral Gessi M, Giangaspero F, Lauriola L, Gardiman M, Scheithauer BW, Halliday W et al (2009) Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor. Am J Surg Pathol 33:211–217CrossRefPubMedPubMedCentral
15.
go back to reference Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M et al (2014) CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol 128:291–303CrossRefPubMedPubMedCentral Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M et al (2014) CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol 128:291–303CrossRefPubMedPubMedCentral
16.
go back to reference Eberhart CG, Brat DJ, Cohen KJ, Burger PC (2000) Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol 3:346–352CrossRefPubMed Eberhart CG, Brat DJ, Cohen KJ, Burger PC (2000) Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol 3:346–352CrossRefPubMed
17.
go back to reference Pfister SM, Korshunov A, Kool M, Hasselblatt M, Eberhart C, Taylor MD (2010) Molecular diagnostics of CNS embryonal tumors. Acta Neuropathol 120:553–566CrossRefPubMedPubMedCentral Pfister SM, Korshunov A, Kool M, Hasselblatt M, Eberhart C, Taylor MD (2010) Molecular diagnostics of CNS embryonal tumors. Acta Neuropathol 120:553–566CrossRefPubMedPubMedCentral
18.
go back to reference Korshunov A, Sturm D, Ryzhova M, Hovestadt V, Gessi M, Jones DTW et al (2014) Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol 128:279–289CrossRefPubMed Korshunov A, Sturm D, Ryzhova M, Hovestadt V, Gessi M, Jones DTW et al (2014) Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol 128:279–289CrossRefPubMed
19.
go back to reference Tsialikas J, Romer-Seibert J (2015) LIN28: roles and regulation in development and beyond. Development 142:2397–2404CrossRefPubMed Tsialikas J, Romer-Seibert J (2015) LIN28: roles and regulation in development and beyond. Development 142:2397–2404CrossRefPubMed
Metadata
Title
LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT)
Authors
Shilpa Rao
R. T. Rajeswarie
T. Chickabasaviah Yasha
Bevinahalli N. Nandeesh
Arimappamagan Arivazhagan
Vani Santosh
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 11/2017
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-017-3551-6

Other articles of this Issue 11/2017

Child's Nervous System 11/2017 Go to the issue